| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.02 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |